Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Epinephrine bitartrate + lidocaine hydrochloride 0.005mg/10mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride 1%/1%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride 1ns/4%wv solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride 1ns/6%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride ns/2%wv solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline acid tartrate 0.01% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline acid tartrate 0.1% preservative-free eye drops (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine hydrochloride 2.5mg/epinephrine bitartrate 5mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine acid tartrate 0.01% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine acid tartrate 0.1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/5 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/5 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/10 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/10 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 5 mg/mL solution for injection |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 5 mg/mL solution for injection |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bupivacaine hydrochloride 2.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline (as adrenaline acid tartrate) 12.5 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection |
Has precise active ingredient |
True |
Epinephrine bitartrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |